DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the Na Products Suppliers
DoP asks NPPA to reconsider retail price fixation on Abbott’s
The DoP took up the matter and examined the argument from both the sides, before arriving at a decision to remand the review petition to the NPPA. Abbott, in its review application said that the NPPA fixed the retail price for the formulation based on recommendations of the Multi Disciplinary Committee (MDC) of Experts, using the average of
DoP asks NPPA to review, verify Bharat Serum and Vaccine's request
The Department of Pharmaceuticals (DoP) has issued an order disposing the review application of Bharat Serum and Vaccine (BSVL) to the National Pharmaceutical Pricing Authority (NPPA) instructing to verify the applicability of GST factor by cross-checking the documents submitted by BSVL pertaining to the formulation Human Normal Immunoglobulin.
DoP asks companies to revise MRP of drugs on which GST rates have been
The Department of Pharmaceuticals (DoP) has directed all the manufacturers and marketing companies to revise the maximum retail price (MRP) of drugs or formulations on which Goods and Services Tax (GST) has been reduced taking into effect the revised rates of GST.
Zydus challenges ceiling prices for 8 formulations, DoP rejects review
In yet another stern stance on implementing the new pharmaceutical pricing policy, the Department of Pharmaceuticals (DoP) has rejected the review petitions by Zydus Healthcare which challenged the price fixation done by the National Pharmaceutical Pricing Authority (NPPA) in case of its eight formulations.
